A novel circular RNA circPPFIA1 promotes laryngeal squamous cell carcinoma progression through sponging miR-340-3p and regulating ELK1 expression

References

• Fu A, Singh K, Abunassar J, et al. Ticagrelor in Triple Antithrombotic Therapy: predictors of Ischemic and Bleeding Complications. Clin Cardiol. 2016;39(1):19–23.
   PubMed Web of Science ®Google Scholar
• Olaleye O, Siddiq S, Ekrikpo U, et al. Regional differences in incidence and mortality trends in cancers of the larynx, thyroid, oral cavity and pharynx in England and Scotland: 1975-2002. Open Epidemiology Journal. 2013;3(2):70–78.
   Google Scholar
• Chu EA, Kim YJ. Laryngeal cancer: diagnosis and preoperative work-up. Otolaryngol Clin North Am. 2008;41(4):673–695.
   PubMed Web of Science ®Google Scholar
• Chang K, Wei Z, Cao H. miR-375-3p inhibits the progression of laryngeal squamous cell carcinoma by targeting hepatocyte nuclear factor-1β. Oncol Lett. 2020;20(4):80.
   PubMed Web of Science ®Google Scholar
• Steuer CE, El-Deiry M, Parks JR, et al. An update on larynx cancer. CA Cancer J Clin. 2017;67(1):31–50.
   PubMed Web of Science ®Google Scholar
• Rudolph E, Dyckhoff G, Becher H, et al. Effects of tumour stage, comorbidity and therapy on survival of laryngeal cancer patients: a systematic review and a meta-analysis. Europ Archiv Oto-rhino-laryngol. 2011;268(2):165–179.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhu W, Tao G, et al. RNA circ-LRP6 facilitates Myc-driven tumorigenesis in esophageal squamous cell cancer. Bioengineered. 2020 Dec;11(1):932–938.
   PubMed Web of Science ®Google Scholar
• Han B, Chao J, Yao H. Circular RNA and its mechanisms in disease: from the bench to the clinic. Pharmacol Ther. 2018;187:31–44.
   PubMed Web of Science ®Google Scholar
• Shang Q, Yang Z, Jia R, et al. The novel roles of circRNAs in human cancer. Mol Cancer. 2019;18(1):6.
   PubMed Web of Science ®Google Scholar
• Zhou WY, Cai ZR, Liu J, et al. Circular RNA: metabolism, functions and interactions with proteins. Mol Cancer. 2020;19(1):172.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wang W, Zhou Q, et al. Roles of circRNAs in the tumour microenvironment. Mol Cancer. 2020;19(1):14.
   PubMed Web of Science ®Google Scholar
• Zhong W, Bao L, Yuan Y, et al. CircRASSF2 acts as a prognostic factor and promotes breast cancer progression by modulating miR-1205/HOXA1 axis. Bioengineered. 2021;12(1):3014–3028.
   PubMed Web of Science ®Google Scholar
• Li J, Sun D, Pu W, et al. Circular RNAs in cancer: biogenesis, function, and clinical significance. Trends Cancer. 2020;6(4):319–336.
   PubMed Web of Science ®Google Scholar
• Cho WC. OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer. 2007 25;6(1):60.
   PubMed Web of Science ®Google Scholar
• Bhat AA, Younes SN, Raza SS, et al. Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance. Mol Cancer. 2020;19(1):57.
   PubMed Web of Science ®Google Scholar
• Tang X, Ren H, Guo M, et al. Review on circular RNAs and new insights into their roles in cancer. Comput Struct Biotechnol J. 2021;19:910–928.
   PubMed Web of Science ®Google Scholar
• Wang R, Ma Z, Feng L, et al. LncRNA MIR31HG targets HIF1A and P21 to facilitate head and neck cancer cell proliferation and tumorigenesis by promoting cell-cycle progression. Mol Cancer. 2018 Nov 20;17(1):162.
   PubMed Web of Science ®Google Scholar
• Shuang Y, Li C, Zhou X, et al. MicroRNA-195 inhibits growth and invasion of laryngeal carcinoma cells by directly targeting DCUN1D1. Oncol Rep. 2017 Oct;38(4):2155–2165.
   PubMed Web of Science ®Google Scholar
• Chen Z, Guo X, Sun S, et al. Serum miR-125b levels associated with epithelial ovarian cancer (EOC) development and treatment responses. Bioengineered. 2020 Dec;11(1):311–317.
   PubMed Web of Science ®Google Scholar
• Wang P, Wu T, Zhou H, et al. Long noncoding RNA NEAT1 promotes laryngeal squamous cell cancer through regulating miR-107/CDK6 pathway. J Exp Clin Cancer Res. 2016 Jan 29;35(1):22.
   PubMed Web of Science ®Google Scholar
• Gao W, Zhang Y, Niu M, et al. Identification of miR-145-5p-Centered Competing Endogenous RNA Network in Laryngeal Squamous Cell Carcinoma. Proteomics. 2019 Nov;19(21–22):e1900020.
   PubMed Web of Science ®Google Scholar
• Liu J, Guan D, Dong M, et al. UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination. Nat Cell Biol. 2020;22(9):1056–1063.
   PubMed Web of Science ®Google Scholar
• Lin XJ, Liu H, Li P, et al. miR-936 suppresses cell proliferation, invasion, and drug resistance of laryngeal squamous cell carcinoma and targets GPR78. Front Oncol. 2020;10:60.
   PubMed Web of Science ®Google Scholar
• Li P, Yang Y, Liu H, et al. MiR-194 functions as a tumor suppressor in laryngeal squamous cell carcinoma by targeting Wee1. J Hematol Oncol. 2017;10(1):32.
   PubMed Web of Science ®Google Scholar
• Yu W, Zhang G, Lu B, et al. MiR-340 impedes the progression of laryngeal squamous cell carcinoma by targeting EZH2. Gene. 2016;577(2):193–201.
   PubMed Web of Science ®Google Scholar
• Liu CY, Huang TT, Huang CT, et al. EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cells. Eur J Cancer. 2017;72:112–123.
   PubMed Web of Science ®Google Scholar
• Montagnani V, Maresca L, Apollo A, et al. E3 ubiquitin ligase PARK2, an inhibitor of melanoma cell growth, is repressed by the oncogenic ERK1/2-ELK1 transcriptional axis. J Biol Chem. 2020;295(47):16058–16071.
   PubMed Web of Science ®Google Scholar
• Bullock M, Lim G, Li C, et al. Thyroid transcription factor FOXE1 interacts with ETS factor ELK1 to co-regulate TERT. Oncotarget. 2016;7(52):85948–85962.
   PubMedGoogle Scholar
• Ma C, Huang S, Xu L, et al. Transcription co-activator P300 activates Elk1-aPKC-iota signaling mediated epithelial-to-mesenchymal transition and malignancy in hepatocellular carcinoma. Oncogenesis. 2020;9(3):32.
   PubMed Web of Science ®Google Scholar
• Kong Y, Yin J, Fu Y, et al. Suppression of Elk1 inhibits thyroid cancer progression by mediating PTEN expression. Oncol Rep. 2018;40(3):1769–1776.
   PubMed Web of Science ®Google Scholar
• Huang B, Chang C, Wang BL, et al. ELK1-induced upregulation of lncRNA TRPM2-AS promotes tumor progression in gastric cancer by regulating miR-195/ HMGA1 axis. J Cell Biochem. 2019;120(10):16921–16933.
   PubMed Web of Science ®Google Scholar
• Zhao G, Dai GJ. Hsa_circRNA_000166 promotes cell proliferation, migration and invasion by regulating miR-330-5p/ELK1 in colon cancer. Onco Targets Ther. 2020;13:5529–5539.
   PubMed Web of Science ®Google Scholar
• Fan HX, Feng YJ, Zhao XP, et al. MiR-185-5p suppresses HBV gene expression by targeting ELK1 in hepatoma carcinoma cells. Life Sci. 2018;213:9–17.
   PubMed Web of Science ®Google Scholar
• Zhao C, Li L, Li Z, et al. A Novel Circular RNA hsa_circRPPH1_015 Exerts an Oncogenic Role in Breast Cancer by Impairing miRNA-326-Mediated ELK1 Inhibition. Front Oncol. 2020;10:906.
   PubMed Web of Science ®Google Scholar